In search of biomarkers for autism: Scientific, social and ethical challenges

Nature Reviews Neuroscience

Volumn 12, Issue 10, 2011, Pages 603-612

  Walsh, Pat ^a   Elsabbagh, Mayada ^b,c   Bolton, Patrick ^a,d   Singh, Ilina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AUTISM; AWARENESS; CLINICAL PRACTICE; COPY NUMBER VARIATION; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; GENETIC DISORDER; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL ASPECT;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 80053003849     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3113     Document Type: Review

References (65)

1. Abrahams, B. S. & Geschwind, D. H. Advances in ASD genetics: on the threshold of a new neurobiology. Nature Rev. Genet. 9, 341-355 (2008). (Pubitemid 351556064)
2. Belmonte. et al. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol. Psychiatry 9, 646-663 (2004). (Pubitemid 38932171)
3. Elsabbagh, M. & Johnson, M. H. Getting answers from babies about autism. Trends Cogn. Sci. 14, 81-87 (2010).
4. Baird, G. et al. Prevalence of disorders of the autistic spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368, 210-215 (2006). (Pubitemid 44037796)
5. Kim, Y. S. et al. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 168, 904-912 (2011).
6. Wing, L. The Autistic Spectrum: A Guide for Parents and Professionals (Constable, London, 1996).
7. Farley, M. A. et al. Twenty-year outcome for individuals with autism and average or near-average cognitive abilities. Autism Res. 2, 109-118 (2009).
8. Burke, W., Laberge, A. M. & Press, N. Debating clinical utility. Public Health Genomics 13, 215-223 (2010).
9. Scherer, S. & Dawson, G. Risk factors for autism: translating genomic discoveries into diagnostics. Hum. Genomics 130, 123-148 (2011).
10. Pellicano, E. & Stears, M. Bridging autism, science and society: moving toward an ethically informed approach to autism research. Autism Res. 4, 271-282 (2011).
11. Murphy, D. et al. Autism in adults. New biological findings and their translational implications to the cost of clinical services. Brain Res. 1380, 22-33 (2011).
12. Plauche Johnson, C. et al. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120, 1183-1215 (2000).
13. Ecker, C. et al. Describing the brain in autism in five dimensions-magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J. Neurosci. 30, 10612-10623 (2010).
14. Ingalhalikar M. et al. DTI based diagnostic prediction of a disease via pattern classification. Med. Image Comput. Comput. Assist. Interv. 13, 558-565 (2010).
15. Lange, N. et al. Atypical diffusion tensor hemispheric asymmetry in autism. Autism Res. 3, 350-358 (2010).
16. Jiao, Y. et al. Predictive models of autism spectrum disorder based on brain regional cortical thickness. Neuroimage 50, 589-599 (2010).
17. Stevenson, J. & Kellett, C. Can. Magnetic resonance imaging aid diagnosis of the autism spectrum? J. Neurosci. 30 16763-16765 (2011).
18. Zwaigenbaum, L. et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 123, 1383-1391 (2009).
19. Dawson, G. Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev. Psychopathol. 20, 775-803 (2008). (Pubitemid 352003597)
20. Bosl, W. et al. EEG complexity as a biomarker for autism spectrum disorder risk. BMC Med. 9, 18 (2011).
21. Pierce, K. et al. Preference for geometric patterns early in life as a risk factor for autism. Arch. Gen. Psychiatry 68, 101-109 (2011).
22. Griffin, R.& Westbury, C. Infant EEG activity as a biomarker for autism: a promising approach or a false promise? BMC Med. 9, 61 (2011).
23. Newschaffer, C. Assessing performance of novel autism screening approaches. Arch. Gen. Psychiatry 68, 101-109 (2011).
24. Chawarska, K. & Shic, F. Looking but not seeing: atypical visual scanning and recognition of faces in 2 and 4-year old children with autism spectrum disorder. J. Autism Dev. Disord. 39, 1663-1672 (2009).
25. Losh, M. et al. Defining key features of the broad autism phenotype: a comparison across parents of multiple-and single-incidence autism families. Am. J. Med. Gen. 147B, 424-433 (2008). (Pubitemid 351830798)
26. Gottesman, I. & Gould, T. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636-645 (2003). (Pubitemid 41079594)
27. Baron-Cohen, S. Is high-functioning autism/Asperger's syndrome necessarily a disability? Dev. Psychopathol. 12, 489-500 (2000).
28. Samson, F., Mottron, L., Soulieres, I. & Zeffiro, T. A. Enhanced visual functioning in autism: an ALE meta-analysis. Hum. Brain Mapp. 4 Apr 2011 (doi:10.1002/hbm.21307).
29. Heaton, P. F. et al. Autism and pitch processing: a precursor for savant musical ability? Music Percept. 15, 291-305 (1998).
30. Asperger, H. The mentally abnormal child. Viennese Clin. Weekly 49, 1-12 (1938).
31. Beardon, L. & Worton, D. (eds) Aspies on Mental Health: Speaking for Ourselves (Jessica Kingsley Publishers, London, 2011).
32. Humphrey, N. & Lewis, S. 'Make me normal': the views and experiences of pupils on the autistic spectrum in mainstream secondary schools. Autism 12, 23-46 (2008).
33. Prince, D. E. An exceptional path: an ethnographic narrative reflecting on autistic parenthood from evolutionary, cultural and spiritual perspectives. Ethos 38, 56-68 (2010).
34. US Department of Health and Human Services. The 2011 Interagency Autism Coordinating Committee Strategic Plan for Autism Spectrum Disorder Research [online], http://iacc.hhs.gov/strategic-plan/2011/index.shtml (2011)
35. UK Department of Health. Towards 'Fulfilling and rewarding lives': The first year delivery plan for adults with autism in England [online], http://www. dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-115115 (2010).
36. Medical Research Council. MRC Autism Forward Look and Review [online], http://www.mrc.ac.uk/Utilities/Documentrecord/index. htm?d=MRC007354 (2010).
37. O'Hara, M. The campaigner bringing people with autism to the policy table. SocietyGuardian (Lond.) 5 (8 Jun 2011).
38. Marx, G. Another view on autism. New Jersey Monthly (26 Jun 2009).
39. Andari, E. et al. Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. Proc. Natl Acad. Sci. USA 107, 4389-4394 (2010).
40. Ablon, J. Living with Genetic Disorder: the Impact of Neurofibromatosis 1 (Auburn House, Westport, Connecticut, 1999).
41. Campbell, E. & Ross, L. Parental attitudes and beliefs regarding the genetic testing of children. Community Genet. 8, 94-102 (2005). (Pubitemid 40827617)
42. Savulescu, J. Procreative beneficence: why we should choose the best children. Bioethics 15, 413-426 (2001). (Pubitemid 33019863)
43. Quigley, M. & Harris, J. in Philosophical Reflections on Disability (eds Ralston, D. C. & Ho, J.) 123-132 (Springer, New York, 2010).
44. Walsh, P. Asperger syndrome and the supposed obligation not to bring disabled lives into the world. J. Med. Ethics 36, 521-524 (2010).
45. Skotko, B. Prenatally diagnosed Downs syndrome: mothers who continued their pregnancies evaluate their health care providers. Am. J. Obstet. Gynecol. 192, 670-677 (2005). (Pubitemid 40311255)
46. Shen, Y. et al. Clinical genetic testing for parents with autism spectrum disorders. Pediatrics 125, 727-735 (2010).
47. Brookes-Howell, L. C. Living without labels: the interactional management of diagnostic uncertainty in the genetic counseling clinic. Soc. Sci. Med. 63, 3080-3091 (2006). (Pubitemid 44648502)
48. Selkirk, C. G. et al. Parents' perceptions if autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: recommendations for genetic counsellors. J. Genet. Couns.18, 507-519 (2009).
49. Fanos, J. H. et al. Attitudes toward prenatal screening and testing for Fragile X. Genet. Med. 8, 129-133 (2006).
50. Miller, F. A. et al. What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur. J. Hum. Genet. 18, 867-871 (2010).
51. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn (American Psychiatric Association, 2000).
52. Georgiades, S. et al. Structure of the autism symptom phenotype: a proposed multidimensional model. J. Am. Acad. Child. Adolesc. Psychiatry 46, 188-196 (2007). (Pubitemid 46148417)
53. Volkmar, F. R., State, M. & Klin, A. Autism and autism spectrum disorders: diagnostic issues for the coming decade. J. Child. Psychol. Psychiatry 50, 108-115 (2009).
54. Anney, R. et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19, 4072-4082 (2010).
55. Wang, K. et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459, 528-533 (2009).
56. Currenti, S. A. Understanding and determining the etiology of autism. Cell. Mol. Neurobiol. 30, 161-171 (2009).
57. Sanders, S. J. et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863-885 (2011).
58. Glannon, W. Neurodiversity. JEMH 2, 1-6 (2007).
59. Holmer Nadeson, M. Constructing Autism: Unravelling the Truth and Understanding the Social (Routledge, London, 2005).
60. Barnbaum, D. R. The Ethics of Autism: Among Them, But Not Of Them (Indiana Univ. Press, Bloomington, Indiana, 2008).
61. Fitzpatrick, M. Defeating Autism (Routledge, London, 2009).
62. Schwarz, E. et al. Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Mol. Psychiatry 28 Sep 2010 (doi:10.1038/mp.2010.102).
63. Yap, I. K. et al. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J. Proteome Res. 9, 2996-3004 (2010).
64. Elder, L. M., Dawson. G., Toth, K., Fein, D. & Munson, J. Head circumference as an early predictor of autism symptoms in younger siblings of children with autism spectrum disorders. J. Autism Dev. Disord. 38, 1104-1111 (2008).
65. Miller, D. T. et al. Consensus statement: chromosmal microoarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86, 749-764 (2010).